Advertisement

Topics

Enbrel Reports

16:53 EDT 26th March 2019 | BioPortfolio

KOL Perspectives: Perceptions of Lupus Pipeline Therapy Data Presented at EULAR 2018 [Report Updated: 18092018] Prices from USD $2500

KOL Perspectives: Perceptions of Lupus Pipeline Therapy Data Presented at EULAR 2018SummaryThis KOL Insight briefing focuses on KOLs views of Pipeline Therapy Data Presented at EULAR 2018.Questions topics Opinion on abatacept failing to achieve its primary endpoint in its Phase III LN trial Views on the Phase III safety data for abatacept in LN Expectations regarding abatacept's future developme...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Enbrel market research data and corporate reports here